Primacy of cardiac chymase over angiotensin converting enzyme as an angiotensin-(1-12) metabolizing enzyme

被引:40
作者
Ahmad, Sarfaraz [1 ]
Varagic, Jasmina [1 ,2 ]
VonCannon, Jessica L. [2 ]
Groban, Leanne [2 ,3 ,4 ]
Collawn, James F. [7 ]
Dell'Italia, Louis J. [8 ]
Ferrario, Carlos M. [1 ,5 ,6 ]
机构
[1] Wake Forest Univ, Sch Med, Gen Surg, Winston Salem, NC 27109 USA
[2] Wake Forest Univ, Sch Med, Hypertens & Vasc Res Ctr, Winston Salem, NC 27109 USA
[3] Wake Forest Univ, Sch Med, Anesthesiol, Winston Salem, NC 27109 USA
[4] Wake Forest Univ, Sch Med, Internal Med Mol Med, Winston Salem, NC 27109 USA
[5] Wake Forest Univ, Sch Med, Internal Med Nephrol, Winston Salem, NC 27109 USA
[6] Wake Forest Univ, Sch Med, Internal Med Cardiovasc Med, Winston Salem, NC 27109 USA
[7] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL USA
[8] Univ Alabama Birmingham, Dept Med, Div Cardiovasc Dis, Birmingham VA Med Ctr, Birmingham, AL 35294 USA
关键词
Rat cardiac chymase; Angiotensin-converting enzyme; Angiotensin-(1-12); Angiotensin I; Angiotensin II; Renin-angiotensin system; BLOOD-PRESSURE; II GENERATION; HIGH-GLUCOSE; SYSTEM; HEART; RATS; PROANGIOTENSIN-12; RECEPTOR; PEPTIDE; LOCALIZATION;
D O I
10.1016/j.bbrc.2016.07.100
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We showed previously that rat angiotensin-(1-12) [Ang-(1-12)] is metabolized by chymase and angiotensin converting enzyme (ACE) to generate Angiotensin II (Ang II). Here, we investigated the affinity of cardiac chymase and ACE enzymes for Ang-(1-12) and Angiotensin I (Ang I) substrates. Native plasma membranes (PMs) isolated from heart and lung tissues of adult spontaneously hypertensive rats (SHR) were incubated with radiolabeled I-125-Ang-(1-12) or I-125-Ang I, in the absence or presence of a chymase or ACE inhibitor (chymostatin and lisinopril, respectively). Products were quantitated by HPLC connected to an in-line flow-through gamma detector. The rate of I-125-Ang II formation from I-125-Ang-(1-12) by chymase was significantly higher (heart: 7.0 +/- 0.6 fmol/min/mg; lung: 33 +/- 1.2 fmol/min/mg, P < 0.001) when compared to I-125-Ang I substrate (heart: 0.8 +/- 0.1 fmol/min/mg; lung: 2.1 +/- 0.1 fmol/min/mg). Substrate affinity of I-125-Ang-(1-12) for rat cardiac chymase was also confirmed using excess unlabeled Ang-(1-12) or Ang I (0-250 mu M). The rate of I-125-Ang II formation was significantly lower using unlabeled Ang-(1-12) compared to unlabeled Ang I substrate. Kinetic data showed that rat chymase has a lower K-m (64 +/- 63 mu M vs 142 +/- 17 mu M), higher V-max (132 +/- 1.3 mu M/min/mg vs 1.9 +/- 0.2 mu M/min/mg) and more than 15-fold higher catalytic efficiency (ratio of V-max/K-m) for Ang-(1-12) compared to Ang I substrate, respectively. We also investigated ACE mediated hydrolysis of I-125-Ang-(1-12) and I-125-Ang I in solubilized membrane fractions of the SHR heart and lung. Interestingly, no significant difference in I-125-Ang II formation by ACE was detected using either substrate, I-125-Ang-(1-12) or I-125-Ang I, both in the heart (1.8 +/- 0.2 fmol/min/mg and 1.8 +/- 0.3 fmol/min/mg, respectively) and in the lungs (239 +/- 25 fmol/min/mg and 248 +/- 34 fmol/min/mg, respectively). Compared to chymase, ACE-mediated Ang-(1-12) metabolism in the heart was several fold lower. Overall our findings suggest that Ang-(1-12), not Ang I, is the better substrate for Ang II formation by chymase in adult rats. In addition, this confirms our previous observation that chymase (rather than ACE) is the main hydrolyzing enzyme responsible for Ang II generation from Ang-(1-12) in the adult rat heart. (C) 2016 Elsevier Inc. All rights reserved.
引用
收藏
页码:559 / 564
页数:6
相关论文
共 50 条
[21]   Cardiac angiotensin-(1-12) expression and systemic hypertension in rats expressing the human angiotensinogen gene [J].
Ferrario, Carlos M. ;
VonCannon, Jessica ;
Jiao, Yan ;
Ahmad, Sarfaraz ;
Bader, Michael ;
Dell'Italia, Louis J. ;
Groban, Leanne ;
Varagic, Jasmina .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2016, 310 (08) :H995-H1002
[22]   Chymase-Dependent Generation of Angiotensin II from Angiotensin-(1-12) in Human Atrial Tissue [J].
Ahmad, Sarfaraz ;
Simmons, Tony ;
Varagic, Jasmina ;
Moniwa, Norihito ;
Chappell, Mark C. ;
Ferrario, Carlos M. .
PLOS ONE, 2011, 6 (12)
[23]   CARDIAC ANGIOTENSIN-II FORMATION - THE ANGIOTENSIN-I CONVERTING-ENZYME AND HUMAN CHYMASE [J].
URATA, H ;
GANTEN, D .
EUROPEAN HEART JOURNAL, 1993, 14 :177-182
[24]   Angiotensin converting enzyme 2 and the kidney [J].
Ortiz-Melo, David I. ;
Gurley, Susan B. .
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2016, 25 (01) :59-66
[25]   Atrial angiotensin-(1-12)/chymase expression data in patient of heart diseases [J].
Wang, Hao ;
Varagic, Jasmina ;
Nagata, Sayaka ;
Kon, Neal D. ;
Ahmad, Sarfaraz ;
VonCannon, Jessica L. ;
Wright, Kendra N. ;
Sun, Xuming ;
Deal, Dwight ;
Groban, Leanne ;
Ferrario, Carlos M. .
DATA IN BRIEF, 2020, 31
[26]   Critical role of the chymase/angiotensin-(1-12) axis in modulating cardiomyocyte contractility [J].
Li, Tiankai ;
Zhang, Xiaowei ;
Cheng, Heng-Jie ;
Zhang, Zhi ;
Ahmad, Sarfaraz ;
Varagic, Jasmina ;
Li, Weimin ;
Cheng, Che Ping ;
Ferrario, Carlos M. .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 264 :137-144
[27]   Angiotensin converting enzyme 2 and atherosclerosis [J].
Wang, Yutang ;
Tikellis, Chris ;
Thomas, Merlin C. ;
Golledge, Jonathan .
ATHEROSCLEROSIS, 2013, 226 (01) :3-8
[28]   Angiotensin-(1-7) with Thioether Bridge: An Angiotensin-Converting Enzyme-Resistant, Potent Angiotensin-(1-7) Analog [J].
Kluskens, Leon D. ;
Nelemans, S. Adriaan ;
Rink, Rick ;
de Vries, Louwe ;
Meter-Arkema, Anita ;
Wang, Yong ;
Walther, Thomas ;
Kuipers, Anneke ;
Moll, Gert N. ;
Haas, Marijke .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2009, 328 (03) :849-854
[29]   Cardioprotective role for angiotensin-(1-7) and angiotensin converting enzyme 2 in the heart [J].
Tallant, E. Ann ;
Ferrario, Carlos M. ;
Gallagher, Patricia E. .
FUTURE CARDIOLOGY, 2006, 2 (03) :335-342
[30]   Angiotensin-converting enzyme activity and inhibition in dogs with cardiac disease and an angiotensin-converting enzyme polymorphism [J].
Meurs, Kathryn M. ;
Stern, Joshua A. ;
Atkins, Clarke E. ;
Adin, Darcy ;
Aona, Brent ;
Condit, Julia ;
DeFrancesco, Teresa ;
Reina-Doreste, Yamir ;
Keene, Bruce W. ;
Tou, Sandy ;
Ward, Jessica ;
Woodruff, Kathleen .
JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM, 2017, 18 (04) :1-4